PMID- 22424555 OWN - NLM STAT- MEDLINE DCOM- 20120808 LR - 20191112 IS - 1875-5631 (Electronic) IS - 1566-5232 (Linking) VI - 12 IP - 2 DP - 2012 Apr 1 TI - Viral and non-viral methods to genetically modify dendritic cells. PG - 127-36 AB - Dendritic cells (DCs) behave as antigenic or tolerogenic immune response inducers depending on the nature of their precursors, their differentiation pathway and their environment. As professional antigen presenting cells (APCs) it has been tempting to genetically modify them in order to improve their capacity to mount appropriate protective immune responses. Gene transfer may also be helpful to investigate fundamental issues about the DC biology. Of note, almost all strategies to deliver genes or interfering RNA into DCs have been used with different success rates. These methods are non-exhaustively presented and discussed here. We focused our attention on promising in vitro as well as in vivo lentiviral- mediated gene delivery solutions into murine or human DCs. FAU - Humbert, Jean-Marc AU - Humbert JM AD - UMR_S INSERM Center for Research in Transplantation and Immunology, Institute for Transplantation, Urology and Nephrology, Universite de Nantes, France. FAU - Halary, Franck AU - Halary F LA - eng PT - Journal Article PT - Review PL - United Arab Emirates TA - Curr Gene Ther JT - Current gene therapy JID - 101125446 SB - IM MH - Animals MH - Dendritic Cells/*immunology/*metabolism MH - *Gene Transfer Techniques MH - Genetic Therapy/methods MH - Genetic Vectors/genetics MH - Humans MH - Immunotherapy/methods MH - Lentivirus/*genetics MH - Mice EDAT- 2012/03/20 06:00 MHDA- 2012/08/09 06:00 CRDT- 2012/03/20 06:00 PHST- 2012/03/09 00:00 [received] PHST- 2012/03/13 00:00 [revised] PHST- 2012/03/13 00:00 [accepted] PHST- 2012/03/20 06:00 [entrez] PHST- 2012/03/20 06:00 [pubmed] PHST- 2012/08/09 06:00 [medline] AID - CGT-EPUB-20120314-002 [pii] AID - 10.2174/156652312800099580 [doi] PST - ppublish SO - Curr Gene Ther. 2012 Apr 1;12(2):127-36. doi: 10.2174/156652312800099580.